In a recent study, Gardner et al reported ATIII deficiency in 5/19 (26%) cases and suggested the use of alternate anti-thrombotic therapies [15]. This evidence concerns the gene SERPINC1 and hyperinsulinemic hypoglycemia, familial, 4.